Literature DB >> 16029420

Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner.

Hideki Murakami1, Heinz Arnheiter.   

Abstract

The microphthalmia transcription factor MITF plays important roles in several cell lineages including retinal and neural crest-derived pigment cells. Previous reports have shown that besides its regulation at the transcriptional level, MITF is also regulated post-translationally by phosphorylation and ubiquitination which affect the protein's activity and stability. Here we demonstrate that in addition, MITF is modified in melanoma cells by small ubiquitin-like modifier (SUMO). In vitro assays further show that sumoylation occurs at two lysine residues, K182 and K316, and depends on SUMO E1 activating enzyme (SAE I/SAE II) and E2 conjugating enzyme (Ubc9). Interestingly, MITF with double lysine 182/316 to arginine mutations, although displaying normal DNA binding, stability and nuclear localization, shows a substantial increase in the transcriptional stimulation of promoters containing multiple but not single MITF binding sites. MITF containing the double lysine-to-arginine substitution also shows enhanced cooperation with Sox10 on the Dct promoter. We conclude that SUMO modification of MITF regulates the protein's transcriptional activity especially with respect to synergistic activation. The results suggest that sumoylation plays a significant role among the multiple mechanisms that regulate MITF during development and in adulthood.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029420      PMCID: PMC1351050          DOI: 10.1111/j.1600-0749.2005.00234.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  53 in total

1.  SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

Authors:  M S Rodriguez; C Dargemont; R T Hay
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

2.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

3.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

4.  Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice.

Authors:  K N Weilbaecher; G Motyckova; W E Huber; C M Takemoto; T J Hemesath; Y Xu; C L Hershey; N R Dowland; A G Wells; D E Fisher
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

5.  Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling.

Authors:  Ken-ichi Yasumoto; Kazuhisa Takeda; Hideo Saito; Ken-ichi Watanabe; Kazuhiro Takahashi; Shigeki Shibahara
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

6.  Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.

Authors:  Kim C Mansky; Uma Sankar; Jiahuai Han; Michael C Ostrowski
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

7.  Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.

Authors:  G Motyckova; K N Weilbaecher; M Horstmann; D J Rieman; D Z Fisher; D E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

8.  A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor.

Authors:  Carmit Levy; Hovav Nechushtan; Ehud Razin
Journal:  J Biol Chem       Date:  2001-11-14       Impact factor: 5.157

9.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.

Authors:  Sha Tian; Hetti Poukka; Jorma J Palvimo; Olli A Jänne
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

10.  Role of Dok1 in cell signaling mediated by RET tyrosine kinase.

Authors:  Hideki Murakami; Yumiko Yamamura; Yohei Shimono; Kumi Kawai; Kei Kurokawa; Masahide Takahashi
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

View more
  35 in total

1.  Interspecies difference in the regulation of melanocyte development by SOX10 and MITF.

Authors:  Ling Hou; Heinz Arnheiter; William J Pavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

2.  MITF and cell proliferation: the role of alternative splice forms.

Authors:  Keren Bismuth; Dragan Maric; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2005-10

3.  Regulation of MITF stability by the USP13 deubiquitinase.

Authors:  Xiansi Zhao; Brian Fiske; Akinori Kawakami; Juying Li; David E Fisher
Journal:  Nat Commun       Date:  2011-08-02       Impact factor: 14.919

4.  A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.

Authors:  Corine Bertolotto; Fabienne Lesueur; Sandy Giuliano; Thomas Strub; Mahaut de Lichy; Karine Bille; Philippe Dessen; Benoit d'Hayer; Hamida Mohamdi; Audrey Remenieras; Eve Maubec; Arnaud de la Fouchardière; Vincent Molinié; Pierre Vabres; Stéphane Dalle; Nicolas Poulalhon; Tanguy Martin-Denavit; Luc Thomas; Pascale Andry-Benzaquen; Nicolas Dupin; Françoise Boitier; Annick Rossi; Jean-Luc Perrot; Bruno Labeille; Caroline Robert; Bernard Escudier; Olivier Caron; Laurence Brugières; Simon Saule; Betty Gardie; Sophie Gad; Stéphane Richard; Jérôme Couturier; Bin Tean Teh; Paola Ghiorzo; Lorenza Pastorino; Susana Puig; Celia Badenas; Hakan Olsson; Christian Ingvar; Etienne Rouleau; Rosette Lidereau; Philippe Bahadoran; Philippe Vielh; Eve Corda; Hélène Blanché; Diana Zelenika; Pilar Galan; François Aubin; Bertrand Bachollet; Céline Becuwe; Pascaline Berthet; Yves Jean Bignon; Valérie Bonadona; Jean-Louis Bonafe; Marie-Noëlle Bonnet-Dupeyron; Fréderic Cambazard; Jacqueline Chevrant-Breton; Isabelle Coupier; Sophie Dalac; Liliane Demange; Michel d'Incan; Catherine Dugast; Laurence Faivre; Lynda Vincent-Fétita; Marion Gauthier-Villars; Brigitte Gilbert; Florent Grange; Jean-Jacques Grob; Philippe Humbert; Nicolas Janin; Pascal Joly; Delphine Kerob; Christine Lasset; Dominique Leroux; Julien Levang; Jean-Marc Limacher; Cristina Livideanu; Michel Longy; Alain Lortholary; Dominique Stoppa-Lyonnet; Sandrine Mansard; Ludovic Mansuy; Karine Marrou; Christine Matéus; Christine Maugard; Nicolas Meyer; Catherine Nogues; Pierre Souteyrand; Laurence Venat-Bouvet; Hélène Zattara; Valérie Chaudru; Gilbert M Lenoir; Mark Lathrop; Irwin Davidson; Marie-Françoise Avril; Florence Demenais; Robert Ballotti; Brigitte Bressac-de Paillerets
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

Review 5.  A conserved role for transcription factor sumoylation in binding-site selection.

Authors:  Emanuel Rosonina
Journal:  Curr Genet       Date:  2019-05-15       Impact factor: 3.886

Review 6.  Pathways from senescence to melanoma: focus on MITF sumoylation.

Authors:  J Leclerc; R Ballotti; C Bertolotto
Journal:  Oncogene       Date:  2017-08-21       Impact factor: 9.867

7.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

8.  Profiling of ubiquitin-like modifications reveals features of mitotic control.

Authors:  Yifat Merbl; Phillipe Refour; Hevan Patel; Michael Springer; Marc W Kirschner
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

9.  miR-148 regulates Mitf in melanoma cells.

Authors:  Benedikta S Haflidadóttir; Kristín Bergsteinsdóttir; Christian Praetorius; Eiríkur Steingrímsson
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

10.  Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.

Authors:  Sarmistha Mukherjee; Monzy Thomas; Nahid Dadgar; Andrew P Lieberman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.